
GLP-1 receptor agonist
Semaglutide
GLP-1 receptor agonist. Supplied for laboratory research use only.
- GLP-1 agonist; FDA-approved as Ozempic, Rybelsus, Wegovy
- Also approved by EMA and TGA (Schedule 4, AU)
- This vial is a separate, unbranded research product
- Supplied for laboratory research use only. Not for human or veterinary use.
90-Day Money-Back Guarantee
Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.
Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.
What it is
Development status
Semaglutide is approved by the FDA as a prescription medicine. FDA approved as Ozempic (type 2 diabetes, injectable, Dec 2017), Rybelsus (type 2 diabetes, oral, 2019), and Wegovy (chronic weight management, injectable, June 2021; an oral Wegovy weight-management tablet was subsequently approved). This product is not that medicine and is supplied for laboratory research use only.
Development status is stated above. No efficacy claim is made on this page.
Shipping & returns
The specifics
The details, if you want them.
Development
Where it is up to.
Peer-reviewed and the basis for FDA/EMA/MHRA/TGA approval as Ozempic, Rybelsus, and Wegovy. This vial is a separate, unapproved research product, not those medicines.
Questions
The questions people actually ask.
What is semaglutide?
Is this the same as Ozempic or Wegovy?
What does "Research Use Only" mean?
How is this vial supplied?
What is your refund policy?